“The shame, the embarrassment, the soul-crushing debt, trying and trying — it’s just like, what more do you have left to give?” — Mahad Minhas, MD, a resident physician at the University of Michigan in Ann Arbor, describing the despair some students experience when they don’t match to a residency program.

“That’s a double win for those men.” — Anthony D’Amico, MD, PhD, of Dana-Farber Cancer Institute in Boston, discussing a possible role for docetaxel in a group of men with unfavorable-risk prostate cancer.

“Year after year drug companies rake in record profits, straining our healthcare system and forcing families to choose between medications and other essentials like food or retirement.” — Rep. Carolyn Maloney (D-N.Y.), chairwoman of the House Oversight and Reform Committee, which recently released a report on drug company spending.

“[W]e found that both patients, who had many risk factors to have really severe COVID-19, had a fever for two days and all their symptoms resolved.” — Jaroslaw Bilinski, MD, PhD, of the Medical University of Warsaw in Poland, on the effect of fecal microbiota transplant on two hospitalized patients with COVID.

“I think the story is still unfolding on the sex biological mechanisms underlying risk for Alzheimer’s disease, particularly from the perspective of pathological markers of tau.” — Rachel Buckley, PhD, of Massachusetts General Hospital in Boston, discussing new research linking endogenous estrogen exposure to Alzheimer’s biomarkers.